Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals

NCT00000664 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Interleukin-2, Polyethylene Glycolated
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)